Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03059030 · ClinicalTrials.gov registry record · NA
Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia
A NA study, sponsored by Northwestern University.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03059030 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 7 participants.
The verdict
NCT03059030, a NA study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Evaluate the safety and efficacy of Yttrium-90 (90Y) radioembolization for the management of thrombocytopenia.
Interventions
- DEVICE TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-03-16 |
| Est. Completion | 2024-04-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03059030
The ClinicalTrials.gov registry entry for NCT03059030 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc. is the first listed.
NCT03059030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03059030 about?
NCT03059030 is a clinical study titled "Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia". Evaluate the safety and efficacy of Yttrium-90 (90Y) radioembolization for the management of thrombocytopenia.
What is the current status of trial NCT03059030?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2017-03-16. Estimated completion is 2024-04-04.
What interventions are being tested in trial NCT03059030?
The interventions under investigation include: TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc. (DEVICE).
Who is sponsoring clinical trial NCT03059030?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.